Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+3.69M
-
Total reported value, excl. options
-
$404M
-
Value change
-
+$41.9M
-
Put/Call ratio
-
0.12
-
Number of buys
-
51
-
Number of sells
-
-34
-
Price
-
$10.95
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2014
108 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2014.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 56M outstanding shares and own 66.08% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (10.7M shares), Abingworth LLP (3.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.43M shares), Murphy Michael R (2.51M shares), ARDSLEY ADVISORY PARTNERS (1.77M shares), Ameriprise Financial Inc (1.73M shares), Consonance Capital Management LP (1.44M shares), Orchard Hill Capital Management LP (1.27M shares), BlackRock Fund Advisors (1.21M shares), and NORTHPOINTE CAPITAL LLC (1.02M shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.